El interés corto en Protalix BioTherapeutics Inc (AMEX:PLX) ha aumentado durante el último período de informe, aumentando en aumento desde 3.33M hasta 3.63M. Esto representa el 4.76% de las acciones disponibles públicamente de la empresa.
El interés en corto en Protalix BioTherapeutics Corp (XASE:PLX) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 546.47K acciones negociadas por día, tomaría 6.64 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|
PLX | Protalix BioTherapeutics, Inc. | 07/31/2025 | 08/11/2025 | 4.76% | 76,282,765 | 3,631,108 | 546,466 | 6.64 | |
PLX | Protalix BioTherapeutics, Inc. | 07/15/2025 | 07/24/2025 | 4.37% | 76,282,765 | 3,330,384 | 678,080 | 4.91 | |
PLX | Protalix BioTherapeutics, Inc. | 06/30/2025 | 07/10/2025 | 4.29% | 76,282,765 | 3,270,635 | 1,932,354 | 1.69 | |
PLX | Protalix BioTherapeutics, Inc. | 06/13/2025 | 06/25/2025 | 1.56% | 76,282,765 | 1,187,764 | 540,317 | 2.2 | |
PLX | Protalix BioTherapeutics, Inc. | 05/30/2025 | 06/10/2025 | 1.25% | 76,282,765 | 956,150 | 824,912 | 1.16 | |
PLX | Protalix BioTherapeutics, Inc. | 05/15/2025 | 05/27/2025 | 1.28% | 76,282,765 | 979,395 | 1,871,372 | 1 | |
PLX | Protalix BioTherapeutics, Inc. | 04/30/2025 | 05/09/2025 | 1.31% | 76,192,797 | 995,483 | 845,626 | 1.18 | |
PLX | Protalix BioTherapeutics, Inc. | 04/15/2025 | 04/25/2025 | 0.99% | 74,799,144 | 740,272 | 662,539 | 1.12 | |
PLX | Protalix BioTherapeutics, Inc. | 03/31/2025 | 04/09/2025 | 1.31% | 74,799,144 | 979,388 | 785,583 | 1.25 | |
PLX | Protalix BioTherapeutics, Inc. | 03/14/2025 | 03/25/2025 | 0.87% | 74,799,144 | 650,638 | 774,497 | 1 | |
PLX | Protalix BioTherapeutics, Inc. | 02/28/2025 | 03/11/2025 | 7.18% | 70,400,142 | 5,054,042 | 577,230 | 8.76 | |
PLX | Protalix BioTherapeutics, Inc. | 02/14/2025 | 02/26/2025 | 6.80% | 70,400,142 | 4,787,415 | 729,318 | 6.56 | |
PLX | Protalix BioTherapeutics, Inc. | 01/31/2025 | 02/11/2025 | 6.10% | 70,400,142 | 4,297,897 | 572,961 | 7.5 | |
PLX | Protalix BioTherapeutics, Inc. | 01/15/2025 | 01/27/2025 | 5.67% | 70,400,142 | 3,993,527 | 792,328 | 5.04 | |
PLX | Protalix BioTherapeutics, Inc. | 12/31/2024 | 01/10/2025 | 4.59% | 70,400,142 | 3,230,814 | 346,710 | 9.32 | |
PLX | Protalix BioTherapeutics, Inc. | 12/13/2024 | 12/24/2024 | 4.57% | 70,400,142 | 3,216,185 | 438,657 | 7.33 | |
PLX | Protalix BioTherapeutics, Inc. | 11/29/2024 | 12/10/2024 | 4.57% | 70,400,142 | 3,215,154 | 586,099 | 5.49 | |
PLX | Protalix BioTherapeutics, Inc. | 11/15/2024 | 11/26/2024 | 4.51% | 70,400,142 | 3,177,594 | 440,513 | 7.21 | |
PLX | Protalix BioTherapeutics, Inc. | 10/31/2024 | 11/11/2024 | 4.41% | 70,309,233 | 3,097,650 | 142,902 | 21.68 | |
PLX | Protalix BioTherapeutics, Inc. | 10/15/2024 | 10/24/2024 | 4.40% | 70,309,233 | 3,096,973 | 119,147 | 25.99 | |
PLX | Protalix BioTherapeutics, Inc. | 09/30/2024 | 10/09/2024 | 4.45% | 70,309,233 | 3,126,674 | 137,232 | 22.78 | |
PLX | Protalix BioTherapeutics, Inc. | 09/13/2024 | 09/24/2024 | 4.65% | 70,309,233 | 3,271,953 | 176,747 | 18.51 | |
PLX | Protalix BioTherapeutics, Inc. | 08/30/2024 | 09/11/2024 | 4.87% | 70,309,233 | 3,421,071 | 131,358 | 26.04 | |
PLX | Protalix BioTherapeutics, Inc. | 07/31/2024 | 08/09/2024 | 4.95% | 70,082,643 | 3,469,073 | 160,899 | 21.56 | |
PLX | Protalix BioTherapeutics, Inc. | 07/15/2024 | 07/24/2024 | 5.18% | 70,082,643 | 3,630,093 | 376,975 | 9.63 | |
PLX | Protalix BioTherapeutics, Inc. | 06/28/2024 | 07/10/2024 | 7.81% | 70,082,643 | 5,470,150 | 1,414,687 | 3.87 | |
PLX | Protalix BioTherapeutics, Inc. | 06/14/2024 | 06/26/2024 | 8.45% | 70,082,643 | 5,919,392 | 238,713 | 24.8 | |
PLX | Protalix BioTherapeutics, Inc. | 05/31/2024 | 06/11/2024 | 9.02% | 70,082,643 | 6,318,609 | 375,080 | 16.85 | |
PLX | Protalix BioTherapeutics, Inc. | 05/15/2024 | 05/24/2024 | 8.93% | 70,082,643 | 6,261,256 | 576,681 | 10.86 | |
PLX | Protalix BioTherapeutics, Inc. | 04/30/2024 | 05/09/2024 | 9.97% | 70,082,643 | 6,985,609 | 405,761 | 17.22 | |
PLX | Protalix BioTherapeutics, Inc. | 04/15/2024 | 04/24/2024 | 9.43% | 71,120,159 | 6,703,631 | 361,665 | 18.54 | |
PLX | Protalix BioTherapeutics, Inc. | 03/28/2024 | 04/09/2024 | 9.08% | 71,120,159 | 6,460,675 | 414,487 | 15.59 | |
PLX | Protalix BioTherapeutics, Inc. | 03/15/2024 | 03/26/2024 | 9.38% | 71,120,159 | 6,674,487 | 440,665 | 15.15 | |
PLX | Protalix BioTherapeutics, Inc. | 02/29/2024 | 03/11/2024 | 9.05% | 71,120,159 | 6,435,679 | 345,228 | 18.64 | |
PLX | Protalix BioTherapeutics, Inc. | 02/15/2024 | 02/27/2024 | 8.66% | 71,020,159 | 6,152,126 | 265,895 | 23.14 | |
PLX | Protalix BioTherapeutics, Inc. | 01/31/2024 | 02/09/2024 | 8.23% | 71,020,159 | 5,842,279 | 250,315 | 23.34 | |
PLX | Protalix BioTherapeutics, Inc. | 01/12/2024 | 01/24/2024 | 8.42% | 71,020,159 | 5,982,467 | 237,645 | 25.17 | |
PLX | Protalix BioTherapeutics, Inc. | 12/29/2023 | 01/10/2024 | 8.22% | 71,020,159 | 5,838,350 | 443,780 | 13.16 | |
PLX | Protalix BioTherapeutics, Inc. | 12/15/2023 | 12/27/2023 | 8.35% | 71,020,159 | 5,932,828 | 320,989 | 18.48 | |
PLX | Protalix BioTherapeutics, Inc. | 11/30/2023 | 12/11/2023 | 8.57% | 71,020,159 | 6,082,994 | 257,761 | 23.6 | |
PLX | Protalix BioTherapeutics, Inc. | 11/15/2023 | 11/27/2023 | 8.39% | 71,020,159 | 5,957,892 | 702,129 | 8.49 | |
PLX | Protalix BioTherapeutics, Inc. | 10/31/2023 | 11/09/2023 | 8.00% | 71,020,159 | 5,681,916 | 395,760 | 14.36 | |
PLX | Protalix BioTherapeutics, Inc. | 10/13/2023 | 10/24/2023 | 8.08% | 69,648,797 | 5,630,888 | 359,828 | 15.65 | |
PLX | Protalix BioTherapeutics, Inc. | 09/29/2023 | 10/10/2023 | 8.17% | 69,648,797 | 5,691,026 | 337,539 | 16.86 | |
PLX | Protalix BioTherapeutics, Inc. | 09/15/2023 | 09/26/2023 | 7.91% | 69,648,797 | 5,509,205 | 519,626 | 10.6 | |
PLX | Protalix BioTherapeutics, Inc. | 08/31/2023 | 09/12/2023 | 8.19% | 69,648,797 | 5,707,603 | 432,257 | 13.2 | |
PLX | Protalix BioTherapeutics, Inc. | 08/15/2023 | 08/24/2023 | 8.61% | 69,648,797 | 5,998,257 | 1,343,453 | 4.46 |
En busca de los valores más cortos?